Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

Share Price is delayed by 15 minutes
Get Live Data
2.625    0.00 (0.00%)
Bid:
2.55
Ask:
2.70
Spread: 0.15 (5.882%)
Market Cap: £123.06m
AEX Live PriceLast checked at - London Stock Exchange

Intraday Aminex Share Chart

Brochure of Particulars

27 Feb 2014 15:51

RNS Number : 1388B
Aminex PLC
27 February 2014
 



 

NOT FOR FORWARDING, RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT, WHICH HAS BEEN PREPARED BY AMINEX PLC, IS AN ADVERTISEMENT AND NOT A PROSPECTUS.

 

AMINEX PLC

("Aminex" or "the Company")

 

BROCHURE OF PARTICULARS

 

Aminex PLC ("Aminex" or "the Company") advises that application has been made to the Irish Stock Exchange and the UK Listing Authority for 67,079,689 Open Offer Shares to be admitted to the Official Lists and application has been made to the Irish Stock Exchange and the London Stock Exchange plc (the ÒLondon Stock ExchangeÓ) for such Placing Shares to be admitted to trading on their respective regulated markets for listed securities. It is expected that such admission will become effective and that dealings will commence in the Placing Shares at 8.00 a.m. on 28 February 2014.

 

This announcement should be read in conjunction with the full text of the prospectus published by the Company on 30 January 2014 ("the Prospectus"). All capitalised/defined terms in this announcement have the same meaning as those contained in the Prospectus.

 

For further information:

Aminex

Brian Hall, Chairman

Jay Bhattacherjee, Chief Executive Officer

Max Williams Chief Financial Officer

Tel: +44 (0) 20 72913100

Davy

Eugenee Mulhern / Brian Garrahy

Tel: +353 (0) 1 6796363

Shore Capital

Jerry Keen / Stephane Auton / Toby Gibbs

Tel: + 44 (0) 20 7408 4090

FTI Consulting

Edward Westropp

Tel +44 (0) 20 7831 3113

 

 

J&E Davy ("Davy") (which is regulated in Ireland by the Central Bank) and Shore Capital Stockbrokers Limited ("Shore Capital") (which is regulated in the UK by the Financial Conduct Authority) are acting exclusively for Aminex in connection with the Placing and Open Offer and the requirements of the Irish Stock Exchange and the UK Listing Authority and for no one else and will not be responsible to any other person for providing the protection afforded to customers of Davy or Shore Capital respectively nor for providing advice in connection with the Placing and Open Offer and this announcement.

 

This announcement has not been approved by the Central Bank, the Financial Services Authority or by any other regulatory authority. This announcement is for information only and does not constitute, or form part of, an offer of, or the solicitation of any offer to subscribe for or buy, any of the Ordinary Shares to be issued or sold in connection with the Placing and/or Open Offer.

 

 

 

The distribution of this announcement may be restricted by law. No action has been taken that would permit the possession or distribution of this announcement in any jurisdiction where action for that purpose is required. This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Placing or the Open Offer.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEUFIWFLSELE
Date   Source Headline
1st Jun 20269:49 amRNSTotal Voting Rights
11th May 20264:07 pmRNSDirector/PDMR Shareholding
11th May 20264:02 pmRNSExercise of Options and Total Voting Rights
30th Apr 20265:29 pmRNSDirector/PDMR Shareholding
28th Apr 20269:11 amRNSFinal Results and Annual Report 2025
12th Mar 20264:43 pmRNSHolding in Company
12th Mar 20264:40 pmRNSPerson Closely Associated Dealing
27th Feb 202612:11 pmRNSExercise of Options and Total Voting Rights
3rd Feb 20261:45 pmRNSNtorya Operations Update
23rd Jan 20267:00 amRNSNtorya to Madimba Pipeline
18th Dec 20257:00 amRNSNtorya Operations Update
31st Oct 20257:00 amRNSTotal Voting Rights
6th Oct 20257:00 amRNSStrategic Placing to fund Aminex to Ntorya Revenue
26th Sep 20257:00 amRNS2025 Half-Yearly Financial Report
27th Aug 20257:00 amRNSNtorya Operations Update
24th Jul 20254:03 pmRNSResult of AGM
17th Jul 202512:00 pmRNSNtorya Operations Update
3rd Jul 20253:15 pmRNSNtorya to Madimba Pipeline Contract Awarded
30th Jun 202511:31 amRNSNotice of AGM
30th Apr 20254:21 pmRNS2024 Annual Report and Accounts
29th Apr 20254:53 pmRNSFinal Results and Annual Report 2024
5th Mar 20257:00 amRNSNtorya Operations Update
30th Sep 20247:00 amRNS2024 Half-Yearly Financial Report
11th Sep 20242:27 pmRNSNtorya Development Licence handover ceremony
27th Jun 202412:55 pmRNSResult of AGM
19th Jun 20243:02 pmRNSDirector/PDMR Dealing
19th Jun 20242:31 pmRNSExercise of Options and Total Voting Rights
3rd Jun 20247:00 amRNSNotice of AGM
23rd May 20244:04 pmRNSNtorya Development Licence Granted
10th May 20247:00 amRNSUpdate on Ntorya to Madimba Pipeline
29th Apr 20247:01 amRNSFinal Results and Annual Report 2023
29th Apr 20247:00 amRNSFunding Facility agreed with Eclipse Investments
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.